Sufentanil Citrate is a Epidural; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Akorn. The primary component is Sufentanil Citrate.
| Product ID | 17478-050_2b2b98f6-225d-4d67-80f5-720e65051478 |
| NDC | 17478-050 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sufentanil Citrate |
| Generic Name | Sufentanil Citrate |
| Dosage Form | Injection |
| Route of Administration | EPIDURAL; INTRAVENOUS |
| Marketing Start Date | 2010-12-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019050 |
| Labeler Name | Akorn |
| Substance Name | SUFENTANIL CITRATE |
| Active Ingredient Strength | 50 ug/mL |
| Pharm Classes | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2010-12-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019050 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-12-01 |
| Marketing Category | NDA |
| Application Number | NDA019050 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-12-01 |
| Marketing Category | NDA |
| Application Number | NDA019050 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-12-01 |
| Ingredient | Strength |
|---|---|
| SUFENTANIL CITRATE | 50 ug/mL |
| SPL SET ID: | 95e639db-1ca3-4328-b347-7ea348f6cc72 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-3382 | Sufentanil Citrate | SUFENTANIL CITRATE |
| 0641-6110 | Sufentanil Citrate | Sufentanil Citrate |
| 0641-6111 | Sufentanil Citrate | Sufentanil Citrate |
| 0641-6112 | Sufentanil Citrate | Sufentanil Citrate |
| 17478-050 | Sufentanil Citrate | Sufentanil Citrate |